Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic fibrinogen infusion in multilevel lumbar spinal fusion
PACTR202609861307035Completed
- Sponsor
- Sahloul Hospital
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Fibrinogen human in musculoskeletal condition (MSK) (2 arms), sponsored by Sahloul Hospital. Primary endpoint: Percentage decrease in hemoglobin concentration. Started Jan 2023; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
musculoskeletal condition (MSK)
Beyond the preview
Go deeper on PACTR202609861307035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609861307035.